CONMED Corporation (CNMD)
Automate Your Wheel Strategy on CNMD
With Tiblio's Option Bot, you can configure your own wheel strategy including CNMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CNMD
- Rev/Share 42.9169
- Book/Share 32.404
- PB 1.2329
- Debt/Equity 0.8793
- CurrentRatio 2.231
- ROIC 0.0678
- MktCap 1237169762.0
- FreeCF/Share 4.7899
- PFCF 8.3456
- PE 11.2201
- Debt/Assets 0.3787
- DivYield 0.02
- ROE 0.1137
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | CNMD | Needham | Buy | Hold | -- | -- | June 12, 2025 |
| Downgrade | CNMD | Stifel | Buy | Hold | -- | $55 | April 28, 2025 |
| Downgrade | CNMD | JP Morgan | Overweight | Neutral | $85 | $70 | Feb. 6, 2025 |
News
Here's Why Conmed (CNMD) is a Strong Growth Stock
Published: December 15, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Conmed (CNMD) is a Strong Value Stock
Published: December 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
CONMED Stock Falls as It Strategically Exits Gastroenterology Portfolio
Published: December 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
CNMD is set to exit its gastroenterology portfolio to streamline its focus on higher-growth surgical platforms and boost long-term margins.
Read More
Why Is Conmed (CNMD) Up 0.1% Since Last Earnings Report?
Published: December 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?
Read More
Here's Why You Should Add CONMED Stock to Your Portfolio Now
Published: December 04, 2025 by: Zacks Investment Research
Sentiment: Positive
CONMED gains momentum from high-margin platforms and supply-chain recovery, even as tariffs and dV5 adoption weigh on near-term margins.
Read More
5 Value Stocks With Exciting EV-to-EBITDA Ratios to Scoop Up
Published: December 04, 2025 by: Zacks Investment Research
Sentiment: Positive
PAGP, EIX, SNX, CNMD and PCG stand out with attractive EV-to-EBITDA ratios and strong earnings outlooks.
Read More
Are Investors Undervaluing CONMED (CNMD) Right Now?
Published: December 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term
Published: November 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
CNMD vs. MMSI: Which Stock Is the Better Value Option?
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Conmed (CNMD) or Merit Medical (MMSI). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Down 16.9% in 4 Weeks, Here's Why Conmed (CNMD) Looks Ripe for a Turnaround
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
The heavy selling pressure might have exhausted for Conmed (CNMD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Read More
Is CONMED (CNMD) Stock Undervalued Right Now?
Published: November 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Conmed (CNMD) is a Top-Ranked Growth Stock: Should You Buy?
Published: November 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Wall Street Analysts Think Conmed (CNMD) Could Surge 25.54%: Read This Before Placing a Bet
Published: November 10, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Conmed (CNMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
Here's Why Conmed (CNMD) is a Strong Momentum Stock
Published: November 10, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
CNMD or MMSI: Which Is the Better Value Stock Right Now?
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Conmed (CNMD) or Merit Medical (MMSI). But which of these two stocks is more attractive to value investors?
Read More
CONMED Q3 Earnings and Revenues Beat Estimates, Margins Contract
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
CNMD beats third-quarter 2025 estimates on strength in surgery segments, but gross and operating margins see sharp contraction.
Read More
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term
Published: September 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why Conmed (CNMD) is a Strong Value Stock
Published: September 17, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Conmed (CNMD) is a Strong Momentum Stock
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
Published: August 27, 2025 by: Zacks Investment Research
Sentiment: Neutral
CNMD's growth drivers - AirSeal, Buffalo Filter, BioBrace, and Foot & Ankle - are offsetting tariffs and supply risks, making the stock worth retaining.
Read More
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
Published: August 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why Conmed (CNMD) is a Strong Growth Stock
Published: August 22, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Why Conmed (CNMD) is a Top Momentum Stock for the Long-Term
Published: August 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term
Published: August 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Positive
CNMD reports solid second-quarter results, driven by improving sales across both segments.
Read More
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Positive
CNMD stock rides high on strong recurring revenues, margin gains, and surgical product growth despite supply and cybersecurity challenges.
Read More
Conmed (CNMD) is a Top-Ranked Value Stock: Should You Buy?
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CONMED Corporation Appoints LaVerne Council as Chair of the Board of Directors
Published: May 21, 2025 by: Business Wire
Sentiment: Neutral
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that LaVerne Council has been appointed to succeed Martha Goldberg Aronson as the new Independent Chair of its Board of Directors, effective May 21, 2025. “LaVerne's extensive experience as a global operations and information technology executive have been invaluable to CONMED, and I know that her experience will continue to serve the Board and the Company well in her new role as Chair of the Board,” said Pat Beyer, P.
Read More
Here's Why Conmed (CNMD) is a Strong Value Stock
Published: May 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
About CONMED Corporation (CNMD)
- IPO Date 1987-07-23
- Website https://www.conmed.com
- Industry Medical - Devices
- CEO Patrick J. Beyer
- Employees 3900